Ozempic is a brand-name prescription drug manufactured by Novo Nordisk, primarily used to treat type 2 diabetes. Its active ingredient, semaglutide, is a GLP-1 receptor agonist that stimulates insulin production and reduces blood sugar levels. Approved by the FDA in 2017, Ozempic has also been studied for weight management in certain patients. It is administered via a once-weekly injection and has gained attention for its role in both diabetes care and obesity treatment.